Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$105.93 - $142.47 $391,623 - $526,711
-3,697 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$128.36 - $272.13 $200,113 - $424,250
-1,559 Reduced 29.66%
3,697 $502,000
Q3 2018

Nov 13, 2018

SELL
$211.18 - $274.49 $829,303 - $1.08 Million
-3,927 Reduced 42.76%
5,256 $1.44 Million
Q2 2018

Aug 14, 2018

SELL
$150.77 - $207.98 $3,920 - $5,407
-26 Reduced 0.28%
9,183 $1.9 Million
Q1 2018

May 15, 2018

BUY
$138.63 - $182.62 $1.28 Million - $1.68 Million
9,209 New
9,209 $1.52 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.82B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.